NATH BIOGENES (INDIA)
Back to Cashflow Statement
|
NATH BIOGENES (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-2.13 Cr | ₹-7.78 Cr | ₹-1.67 Cr | ₹-22 Cr | ₹5.74 Cr |
What is the latest Cash Flow from Financing Activities ratio of NATH BIOGENES (INDIA) ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-2.13 Cr |
| Mar2024 | ₹-7.78 Cr |
| Mar2023 | ₹-1.67 Cr |
| Mar2022 | ₹-22 Cr |
| Mar2013 | ₹5.74 Cr |
How is Cash Flow from Financing Activities of NATH BIOGENES (INDIA) Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2.13 Cr | Negative | |
| Mar2024 | ₹-7.78 Cr | Negative | |
| Mar2023 | ₹-1.67 Cr | Negative | |
| Mar2022 | ₹-22 Cr | Negative | |
| Mar2013 | ₹5.74 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹321.8 Cr | -4.4% | -3.8% | -7.4% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,408.3 Cr | -1.3% | -14% | -40.3% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,972.7 Cr | -2.3% | -11.9% | -13% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,057.2 Cr | -0.2% | 1.9% | 5.3% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹975.9 Cr | -3.9% | NA | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹510.8 Cr | 1% | 11.9% | 16.3% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -4.4% |
-3.8% |
-7.4% |
| SENSEX | -0.7% |
-3.6% |
-9.1% |
You may also like the below Video Courses